Drugs & Targets VieCure, N-Power Medicine partner to expand clinical trial access in community oncology September 19, 2025Vol.51 No.34
Drugs & Targets Quest Diagnostics launches pharmacogenomics lab testing September 19, 2025Vol.51 No.34
Drugs & Targets FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer September 12, 2025Vol.51 No.33
Drugs & Targets FDA grants Hernexeo Breakthrough Therapy designation as first line use for HER2-mutant advanced NSCLC September 12, 2025Vol.51 No.33
Drugs & Targets FDA seeks academic and patient advocate research partners for oncology data analysis September 12, 2025Vol.51 No.33
Drugs & Targets FDA approves expanded indication for Avtozma intravenous formulation in cytokine release syndrome September 05, 2025Vol.51 No.32
Drugs & Targets FDA grants breakthrough designation for Rina-S in advanced endometrial cancer September 05, 2025Vol.51 No.32
